BioNTech SE Sustainability Reports
BioNTech SE is a biotechnology company that develops next-generation immunotherapies and vaccines for cancer and infectious diseases. The company pioneers mRNA-based therapies, next-generation immunomodulators, and antibody-drug conjugates to leverage the human immune system.
Sector: Professional & technical services
Country: Germany
Exchange: Deutsche Börse (Xetra)
ISIN: US09075V1026
16 reports from 2019 to 2025